Skip to main content






Mothers and Newborns Affected by Opioids – Neonatal






64%

Percentage increase in the Neonatal Abstinence Syndrome (NAS) rate between 2011 and 2017.

88

The number of hospitals participating in MNO-Neonatal Initiative.

55%

The percentage reduction in opioid exposed newborns receiving pharmacologic treatment for NAS Symptoms through optimizing non-pharmacologic care as of September 2019.

2.9

The reduction in average length of stay for opioid exposed newborns (in days).
Clinical Quick Start Resources

Implementing System-Wide Protocols and Clinical Culture Changes to Improve Outcomes for Opioid-Exposed Newborns


Working with hospital-based teams, the Illinois Perinatal Quality Initiative (ILPQC) in 2018 launched a statewide neonatal initiative to implement American Academy of Pediatric recommended guidelines for Opioid Exposed Newborns. ILPQC worked with hospital teams to implement system changes such as implementation of standardized assessment of NAS symptoms (e.g. Eat Sleep Console, Modified Finnegan); engaging mothers/families in optimizing non-pharmacologic care as the first line of treatment for NAS (e.g. rooming-in, breastfeeding); and coordinated discharge planning in conjunction with the care team, mother/family, and community pediatrician to improve newborn outcomes.

Objectives:


  • 1
    Decrease the proportion of OENs receiving pharmacologic treatment to below 20%
  • 2.

    Increase the proportion of eligible OENs receiving maternal breastmilk to above 70%

  • 3.
    Increase proprotion of OENs discharged with a coordinated discharge plan to above 95%

Webinars


Toolkit


**Key Resource
The following material is an example only and not meant to be prescriptive. The resources provided in this toolkit are for informational purposes only. The exclusion of a resource, program, or website does not reflect the quality of that resource, program or website. Note: websites and URLs are subject to change.

Clinical Quick Start Resources